Conference Schedule
26 June 2025
09:00
Opening Remarks from the Conference Chairs
Ernst Bos, Global Medical Director, Roche
Paul Cooper, Personalised Healthcare Strategy Leader, Roche
CONTENT BLOCK 1
INDUSTRY TRENDS AND INNOVATIONS
09:05
FIRESIDE EXPERT KICK-OFF
Industry Trends: Innovations in Clinical Trial Design and Execution
• Innovations in Design (AI/ML, Knowledge Management)
• Innovations in Execution (DHTs, Decentralized Trials, and Site Experience)
Isabela Niculae, Head, Clinical Innovation and Digital Solutions, Global Clinical Operations, UCB
Joachim Lövin, DCT Specialist, Novo Nordisk
Additional Panelists TBA
09:30
CASE STUDY
Optimizing Drug Development with Actionable Data Insights:
Secondary Use of Data: Multimodal Data Assets
• Roche's Approach and Leadership in Data Re-use - ROI and Responsibility to Patients
• Development of Datamarts to Generate Insights for Study and CDP Design
Marta Carrasco, Biomedical Data Insights Development Leader, Roche
09:50
CASE STUDY
Patient Recruitment Enabled through EHRs
Nadir Ammour, Global Lead, Clinical Innovation & External Partnerships, Sanofi
10:10
Transforming the Clinical Trial Industry with a Patient First Mindset
Alison Holland, Chief Customer Officer, Medable
CONTENT BLOCK 2
Accelerating Patient-Centric Trials
11:00
CASE STUDY
Navigating Operational Challenges of Multimodal DHT Trials
Speaker TBA
11:20
CASE STUDY
Scaling Clinical Innovation - The Novartis Operating Model for Sustainable Success
This session will explore how Novartis’s Clin Ops Innovation team is transforming clinical operations. Discover how their comprehensive operating model scales innovation through a structured framework, ensuring alignment with operational needs and challenges. Learn how they measure success with clear criteria, match specific innovations to operational requirements, and consistently assess the innovation landscape to identify new opportunities. This session will provide valuable insights into Novartis’s systematic approach to driving sustainable, value-driven innovation in clinical trials.
Scott Askin, Portfolio Innovation Director, Global Clinical Operations, Novartis
11:40
Bringing Clinical Trials Direct-to-Patient
Speaker TBA, Cambridge Cognition
12:00
PANEL
Identifying Innovations & Technologies Accelerating Patient-Centric Trials
Lauren Sunshine, Director, Product Management, Digital Health, Bristol Myers Squibb
Bola Grace, Senior Director, Digital Health, Digital Biomarkers, GSK
Sam Hariry, Global Head, Clinical Innovation, Novartis Institutes for BioMedical Research (NIBR)
CONTENT BLOCK 3
Enhancing Diversity in Clinical Trials
13:30
PANEL
Patient Perspectives & Cultural Considerations in Clinical Trials
This panel will bring together a group of patients to explore how their perspectives on cultural considerations in clinical trials.
Moderated by: Steve Bourke, Founder, PersonalPulse
13:50
CASE STUDY
IHI READI
This session will explore the collaboration behind the IHI-funded project - IHI READI - aimed at fostering a more cohesive and integrated clinical studies ecosystem for underserved (US) and underrepresented (UR) communities.
Lea Proulx, Patient Voice Partner, Roche
14:10
CASE STUDY
End to End Inclusive Research
What can early development bring to late stage development?
Thierry Lave, R&D Academy and Faculty Lead, Roche
14:30
FIRESIDE CHAT
Site Perspective on Diversity in Clinical Trials
• How are sites addressing recruitment diversity? How are patients actively participating in this discussion?
• How are people managing trust in the clinical trial system with the trust of digital health technologies?
Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare, NHS Trust
CONTENT BLOCK 4
IDEAS INTO ACTION
15:20
Driving AI Adoption within Clinical Operations
Speaker TBA
15:40
CASE STUDY
How MindMed is Deploying AI to do Analysis of Patient Interviews Around the Primary Endpoint of All Clinical Studies
Dan Karlin, Chief Medical Officer, MindMed
16:00
Patient Perspective: First Hand Experience with DCTs
Patient Speaker TBA
16:25
CLOSING PANEL
Challenges of Implementation of DHTs
Meri Kay Scott, Associate Vice President, Digital Health R&D, Eli Lilly & Company
Suki Balendra, Director of Strategic Partnerships, Imperial College Healthcare, NHS Trust
Matteo Lai, CEO, Empatica
Ernst Bos, Global Medical Director, Roche
Paul Cooper, Personalised Healthcare Strategy Leader, Roche
APÉRO & NETWORKING RECEPTION TO FOLLOW!